BAC
Bank of America Corporation
BAC has slightly lower modeled downside risk, despite its lower overall score.
BN
Brookfield Corporation
BN has the edge over BAC overall, supported by stronger modeled upside.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
BN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
BN's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like BN.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over BN in the historical PE scenario, which offers more potential upside but is not a forecast.
BN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $41.64 | — |
| Cheap | 20x | $10.94 | -74% |
| Fair | 71x | $39.79 | -4.4% |
| Current | 75x | $41.64 | — |
| Expensive | 130x | $72.77 | +75% |
Historical ranges are pointers, not guarantees.
BN's PE is in its fair range at 75x. If earnings grow as analysts expect, today's price would be 13x next year's earnings, in its cheap range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
BN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for BN, with profitability holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over BN on earnings, with more consistent year-over-year improvement.
BN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.22 | +475% |
| Q2 2026 | $0.56 | +87% |
| Q1 2026 | $0.52 | +160% |
| Q4 2025 | $0.49 | +133% |
| Q3 2025 | $0.36 | +13% |
| Q2 2025 | $0.30 | -21% |
| Q1 2025 | $0.20 | -50% |
| Q4 2024 | $0.21 | -49% |
| Q3 2024 | $0.32 | +$0.34 |
BN's earnings per share have fallen from their peak: $0.56 over the past year, against $1.66 in late 2019.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over BN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over BN on profitability, with a higher operating margin.
BN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $19.3B | +6.6% |
| Q1 2026 | $18.4B | +2.5% |
| Q4 2025 | $21.2B | +9% |
| Q3 2025 | $18.9B | -8.3% |
| Q2 2025 | $18.1B | -22% |
| Q1 2025 | $17.9B | -22% |
| Q4 2024 | $19.4B | -21% |
| Q3 2024 | $20.6B | -16% |
BN's revenue is recovering but still below its 2023 peak: $19.3B last quarter, up 6.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 24% | +1.3 points |
| Q1 2026 | 24% | -1.1 points |
| Q4 2025 | 42% | +16 points |
| Q3 2025 | 23% | -2.9 points |
| Q2 2025 | 23% | +6.1 points |
| Q1 2025 | 25% | +8.2 points |
| Q4 2024 | 26% | +9.9 points |
| Q3 2024 | 26% | +12 points |
BN's operating margin was 24% last quarter, up 1.3 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over BN on cash generation, producing positive trailing cash flow while its opponent burns cash.
BN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.8B | -$1B |
| Q1 2026 | -$5.6B | -$4.5B |
| Q4 2025 | $0 | +$24.5M |
| Q3 2025 | -$919.1M | -238% |
| Q2 2025 | -$750M | +$943.6M |
| Q1 2025 | -$1.1B | +$1.5B |
| Q4 2024 | -$24.5M | +$1.2B |
| Q3 2024 | $665.5M | -48% |
BN's free cash flow was −$8.3B over the past year, against −$1.2B the year before. Free cash flow isn't a meaningful measure for financial services companies like BN.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over BN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
BN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +0.3% | +8M shares |
| 3 years | 0% | -600K shares |
| 5 years | +1.8% | +42M shares |
| Available history | +7.3% | +162M shares |
BN has 2.4B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $109.6M |
| Q1 2026 | $431.9M |
| Q4 2025 | — |
| Q3 2025 | $35.4M |
| Q2 2025 | $293.6M |
| Q1 2025 | $567.3M |
| Q4 2024 | $136.3M |
| Q3 2024 | $79.4M |
BN spent $577M buying back its own shares over the past year, down 46% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC has the edge over BN on leverage, with a lower net debt burden relative to earnings.
BN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 7.5x | High |
| Q1 2026 | 7.5x | High |
| Q4 2025 | 9.0x | High |
| Q3 2025 | 7.9x | High |
| Q2 2025 | 7.7x | High |
| Q1 2025 | 8.1x | High |
| Q4 2024 | 7.5x | High |
| Q3 2024 | 7.3x | High |
BN's net debt is about 7.5 years of its operating earnings (EBITDA), down from 7.7 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BN.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
BN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.0 | Neutral |
| Stochastic | 51.5 | Neutral |
BN's weekly RSI is 53 (neutral) and its Stochastic is 52 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over BN on valuation relative to its sector.
BN PE vs Financial Services Sector
| Metric | BN | Sector median | Relative |
|---|---|---|---|
| PE | 75x | 13x | 473% above |
| PE % | 54 | 63 | 9 pts below |
BN is trading at 75x earnings, a 473% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
BN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $38.5 | 8.2% above |
| 20 week MA | $40.5 | 2.8% above |
| 50 week MA | $43.0 | 3.1% below |
| 100 week MA | $41.8 | 0.4% below |
| 200 week MA | $34.2 | 22% above |
BN has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over BN on returns for 2026, with the stronger performance.
BN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $20.7 | $21.9 | +5.6% |
| 2021 | $21.9 | $32.3 | +48% |
| 2022 | $32.3 | $21.2 | -35% |
| 2023 | $21.2 | $26.8 | +26% |
| 2024 | $26.8 | $38.1 | +43% |
| 2025 | $38.1 | $46.7 | +23% |
| 2026 YTD | $46.7 | $41.6 | -11% |
BN has finished higher in five of the last six years. It's down 11% so far in 2026.